All too often, underserved and non-white populations are the very last to benefit from the latest advancements in science and medicine. In the aftermath of centuries of racist and discriminatory policies and practices, these same communities live shorter lives and bear a heavier burden of common diseases like high blood pressure, asthma, diabetes, cancer, mental illness, and COVID-19. Co-directed by two senior scientists, Carol Horowitz, MD, MPH, and Lynne Richardson, MD, the Mount Sinai Institute for Health Equity Research brings together a multidisciplinary team of experts to address the longstanding disparities in health and health care that are pervasive in our country. Our team conducts paradigm-shifting research to engage at-risk communities, facilitate access to life-changing resources, and inform life-saving interventions.
To examine the causes and magnitude of health and health care disparities affecting nonwhite, low-income, immigrant, uninsured, LGBTQ+, and other vulnerable populations across all ages, abilities, and genders in order to will devise, test, and implement innovative solutions to eliminate disparities in health while fostering long-term collaborations with community organizations and policymakers.
Systems are designed to bring about precisely the results they do, and when the results are not fair or equitable, systems must be redesigned. With the Institute for Health Equity Research, that is exactly what we are doing. It is only by learning from and with the people most affected by systemic inequities that we can shed light on health-related problems that disproportionately impact at-risk groups across disease areas, while factoring in race, ethnicity, age, sexual orientation, gender identity, ability, poverty, and place of residence. This impactful work will amplify the voices of those who have been silenced by systems of oppression as we strive to ensure a more equitable future for all.